80 research outputs found

    Multi vegetation model evaluation of the Green Sahara climate regime

    Get PDF
    During the Quaternary, the Sahara desert was periodically colonized by vegetation, likely because of orbitally induced rainfall increases. However, the estimated hydrological change is not reproduced in climate model simulations, undermining confidence in projections of future rainfall. We evaluated the relationship between the qualitative information on past vegetation coverage and climate for the mid-Holocene using three different dynamic vegetation models. Compared with two available vegetation reconstructions, the models require 500–800 mm of rainfall over 20°–25°N, which is significantly larger than inferred from pollen but largely in agreement with more recent leaf wax biomarker reconstructions. The magnitude of the response also suggests that required rainfall regime of the early to middle Holocene is far from being correctly represented in general circulation models. However, intermodel differences related to moisture stress parameterizations, biases in simulated present-day vegetation, and uncertainties about paleosoil distributions introduce uncertainties, and these are also relevant to Earth system model simulations of African humid periods

    Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

    Get PDF

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    Get PDF
    Aims  The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and Type 5, related to coronary artery bypass surgery. Low-density lipoprotein cholesterol (LDL-C) reduction with statins and proprotein convertase subtilisin–kexin Type 9 (PCSK9) inhibitors reduces risk of MI, but less is known about effects on types of MI. ODYSSEY OUTCOMES compared the PCSK9 inhibitor alirocumab with placebo in 18 924 patients with recent acute coronary syndrome (ACS) and elevated LDL-C (≥1.8 mmol/L) despite intensive statin therapy. In a pre-specified analysis, we assessed the effects of alirocumab on types of MI. Methods and results  Median follow-up was 2.8 years. Myocardial infarction types were prospectively adjudicated and classified. Of 1860 total MIs, 1223 (65.8%) were adjudicated as Type 1, 386 (20.8%) as Type 2, and 244 (13.1%) as Type 4. Few events were Type 3 (n = 2) or Type 5 (n = 5). Alirocumab reduced first MIs [hazard ratio (HR) 0.85, 95% confidence interval (CI) 0.77–0.95; P = 0.003], with reductions in both Type 1 (HR 0.87, 95% CI 0.77–0.99; P = 0.032) and Type 2 (0.77, 0.61–0.97; P = 0.025), but not Type 4 MI. Conclusion  After ACS, alirocumab added to intensive statin therapy favourably impacted on Type 1 and 2 MIs. The data indicate for the first time that a lipid-lowering therapy can attenuate the risk of Type 2 MI. Low-density lipoprotein cholesterol reduction below levels achievable with statins is an effective preventive strategy for both MI types.For complete list of authors see http://dx.doi.org/10.1093/eurheartj/ehz299</p

    Effect of alirocumab on mortality after acute coronary syndromes. An analysis of the ODYSSEY OUTCOMES randomized clinical trial

    Get PDF
    Background: Previous trials of PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibitors demonstrated reductions in major adverse cardiovascular events, but not death. We assessed the effects of alirocumab on death after index acute coronary syndrome. Methods: ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) was a double-blind, randomized comparison of alirocumab or placebo in 18 924 patients who had an ACS 1 to 12 months previously and elevated atherogenic lipoproteins despite intensive statin therapy. Alirocumab dose was blindly titrated to target achieved low-density lipoprotein cholesterol (LDL-C) between 25 and 50 mg/dL. We examined the effects of treatment on all-cause death and its components, cardiovascular and noncardiovascular death, with log-rank testing. Joint semiparametric models tested associations between nonfatal cardiovascular events and cardiovascular or noncardiovascular death. Results: Median follow-up was 2.8 years. Death occurred in 334 (3.5%) and 392 (4.1%) patients, respectively, in the alirocumab and placebo groups (hazard ratio [HR], 0.85; 95% CI, 0.73 to 0.98; P=0.03, nominal P value). This resulted from nonsignificantly fewer cardiovascular (240 [2.5%] vs 271 [2.9%]; HR, 0.88; 95% CI, 0.74 to 1.05; P=0.15) and noncardiovascular (94 [1.0%] vs 121 [1.3%]; HR, 0.77; 95% CI, 0.59 to 1.01; P=0.06) deaths with alirocumab. In a prespecified analysis of 8242 patients eligible for ≥3 years follow-up, alirocumab reduced death (HR, 0.78; 95% CI, 0.65 to 0.94; P=0.01). Patients with nonfatal cardiovascular events were at increased risk for cardiovascular and noncardiovascular deaths (P<0.0001 for the associations). Alirocumab reduced total nonfatal cardiovascular events (P<0.001) and thereby may have attenuated the number of cardiovascular and noncardiovascular deaths. A post hoc analysis found that, compared to patients with lower LDL-C, patients with baseline LDL-C ≥100 mg/dL (2.59 mmol/L) had a greater absolute risk of death and a larger mortality benefit from alirocumab (HR, 0.71; 95% CI, 0.56 to 0.90; Pinteraction=0.007). In the alirocumab group, all-cause death declined wit h achieved LDL-C at 4 months of treatment, to a level of approximately 30 mg/dL (adjusted P=0.017 for linear trend). Conclusions: Alirocumab added to intensive statin therapy has the potential to reduce death after acute coronary syndrome, particularly if treatment is maintained for ≥3 years, if baseline LDL-C is ≥100 mg/dL, or if achieved LDL-C is low. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01663402

    Image processing for old movies by filters with motion detection

    No full text
    Old movies suffer from various types of degradation: severe noise, blurred edges of objects (low contrast), scratches, spots, etc. Finding an efficient denoising method is one of the most important and one of the oldest problems in image sequence processing. The crucial thing in image sequences is motion. If the motion is insignificant, then any motion noncompensated method of filtering can be applied. However, if the noise is significant, then this approach gives most often unsatisfactory results. In order to increase the quality of frames, motion compensated filters are usually applied. This is a very time consuming and awkward approach due to serious limitations of optical flow methods. In this paper, a review of various filters with motion detection when applied to the processing of image sequences coming from old movies is presented. These filters are nonlinear and based on the concept of multistage median filtering or mathematical morphology. Some new filters are proposed. The idea of these new filters presented here is to detect moving areas instead of performing full estimation of motion in the sequence and to apply exclusively 2D filters in those regions while applying 3D motion noncompensated filters in static areas, which usually significantly reduces the computational burden

    Fischer and Schrock Carbene Complexes: A Molecular Modeling Exercise

    No full text

    Roughness Effects in Surface Enhanced Raman Scattering - Evidence for Electromagnetic and Charge Transfer Enhancement Mechanism

    No full text
    Investigations of Surface Enhanced Raman Scattering (SERS) of pyridine adsorbed on the silver electrode of different roughness have been performed. The obtained results indicate that the micro- and the atomic scale roughness influence the intensity of SERS signal. This proves for the electromagnetic and charge transfer origin of the enhancement in the SERS phenomenon

    Tendencies of development of wrappers construction for predrying forage in bale

    No full text
    W artykule dokonano podziału owijarek ze względu na sposób działania. Opisano budowę i działanie typowych maszyn. Zwrócono uwagę na sposoby nakładania folii na belę i jakość folii.The paper presents wrappers classification in view of operation manner. There are presented construction and operation of typical machines. Notice on methods of imposition foil on bale and foil quality

    Analysis of possibilities to use different round bale wrappers to prepare bales with half-dried green fodder

    No full text
    W artykule dokonano podziału owijarek ze względu na, sposób załadunku bel na stół roboczy oraz współpracę z ciągnikiem jako zawieszane i przyczepiane oraz współpracujące bezpośrednio z prasami zwijającymi. Opisano budowę i działanie maszyn.The paper presents review of round bale wrappers including such aspects as: loading of table with bale, mounted and semimounted version of the machinery as well as the wrappers directly connected with round balers. Constructional and operational aspects of the machines have been described
    corecore